Julie Breneiser, PA-C
Gorlin Syndrome Alliance
Julie Breneiser, PA-C is listed at Gorlin Syndrome Alliance. Julie is scheduled to speak at American Academy of Dermatology Annual Meeting 2027 on 22 March 2027.
Compiled from published conference agendas; not yet confirmed by Julie. Is this you? Claim this profile.
About
Julie Breneiser, PA-C (Emeritus) is the Associate Director of the Gorlin Syndrome Alliance (GSA). Prior to this, she was Executive Director for five years, and President of the Board of Directors. Her early career began as a Physician Assistant. Julie and her two young adult children are affected with Gorlin syndrome, a rare genetic disorder caused by a tumor suppressant mutation that can affect every organ system. The work that Julie does with the GSA focuses on collaboration with industry to bring potential treatments to clinical trial and market. Under her leadership, the GSA conducted a Listening Session (2020) and an Externally Led - Patient Focused Drug Development meeting (2021) for the FDA and interested industry In November of 2021, Julie was honored with an appointment to the Patient Engagement Collaborative at the FDA. She previously served as a consumer reviewer for the National Institutes of Health (NIH) and the Department of Defense’s Congressionally Directed Medical Rese
Upcoming
American Academy of Dermatology Annual Meeting 2027 19 March 2027 – 23 March 2027
- Updates in Cutaneous Oncology Speaker · 22 March 2027
Spoke alongside
People who have shared a session with Julie at events on B2DB.
- Allison Weinkle, MD, FAAD 1 shared session
- Ellen J. Kim, MD, FAAD Department of Dermatology, Perelman School of Medicine 1 shared session
- Jayne S. Joo, MD, FAAD 1 shared session
- Kenneth Y. Tsai, MD, PhD, FAAD Vice Chair of Research, Department of Pathology · Moffitt Cancer Center 1 shared session
- Vernon Sondak, MD Moffitt Cancer Center 1 shared session